Open-label, phase I, dose escalation study to assess safety...

European Urology Supplements 2019 / 03 Vol. 18; Iss. 1

Open-label, phase I, dose escalation study to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E (GEN0101) in castration-resistant prostate cancer patients

Fujita, K., Nakai, Y., Kato, D., Kawashima, A., Ujike, T., Nagahara, A., Uemura, M., Imamura, R., Okihara, K., Ukimura, O., Kaneda, Y., Nonomura, N.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)30876-0
Date:
March, 2019
File:
PDF, 87 KB
2019
Conversion to is in progress
Conversion to is failed